151
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood–brain barrier

, , &
Pages 3679-3687 | Published online: 26 Jun 2018

References

  • PatrickDLAlthofSEPryorJLPremature ejaculation: an observational study of men and their partnersJ Sex Med20052335836716422867
  • GiulianoFHellstromWJThe pharmacological treatment of premature ejaculationBJU Int200810266867518485043
  • McMahonCGDapoxetine: a new option in the medical management of premature ejaculationTher Adv Urol20124523325123024705
  • KimJOSahayGKabanovAVBronichTKPolymeric micelles with ionic cores containing biodegradable cross-links for delivery of chemotherapeutic agentsBiomacromolecules201011491992620307096
  • HsuCHKuoSWChenJKKoFHLiaoCSChangFCSelf-assembly behavior of AB diblock and CD random copolymer mixtures in the solution state through mediated hydrogen bondingLangmuir2008247727773418590284
  • DengCJiangYChengRMengFZhongZBiodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospectsNano Today20127467480
  • DischerDEAhmedFPolymersomesAnnu Rev Biomed Eng2006832334116834559
  • ZhangKTangXZhangJPEG–PLGA copolymers: their structure and structure-influenced drug delivery applicationsJ Control Release2014183778624675377
  • JonesMCLerouxJCPolymeric micelles–a new generation of colloidal drug carriersEur J Pharm Biopharm199948210111110469928
  • GaoWPBaiYChenEQControlling vesicle formation via interpolymer hydrogen-bonding complexation between poly (ethylene oxide)-block-polybutadiene and poly (acrylic acid) in solutionMacromolecules20063948944898
  • MatsumuraYHamaguchiTUraTPhase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicinBr J Cancer200491101775178115477860
  • YokoyamaMPolymeric micelles as a new drug carrier system and their required considerations for clinical trialsExpert Opin Drug Deliv20107214515820095939
  • SwierczewskaMLeeKCLeeSWhat is the future of PEGylated therapies?Expert Opin Emerg Drugs201520453153626583759
  • WangYWenQChoiSFDA’s Regulatory Science Program for generic PLA/PLGA-based drug productsAm Pharm Rev201619459
  • BanksWACharacteristics of compounds that cross the blood–brain barrierBMC Neurol20099suppl 1S319534732
  • ChenYLiuLModern methods for delivery of drugs across the blood–brain barrierAdv Drug Deliv Rev201264764066522154620
  • SaraivaCPraçaCFerreiraRSantosTFerreiraLBernardinoLNanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseasesJ Control Release2016235344727208862
  • KabanovAVBatrakovaEVMillerDWPluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrierAdv Drug Deliv Rev200355115116412535579
  • EtameABSmithCAChanWCWRutkaJTDesign and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculatureNanomedicine201176992100021616168
  • HanadaSFujiokaKInoueYKanayaFManomeYYamamotoKCell-based in vitro blood–brain barrier model can rapidly evaluate nanoparticles’ brain permeability in association with particle size and surface modificationInt J Mol Sci20141521812182524469316
  • González-MariscalLTapiaRChamorroDCrosstalk of tight junction components with signaling pathwaysBiochim Biophys Acta20081778372975617950242
  • WatsonPMAndersonJMVanltallieCMDoctrowSRThe tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriersNeurosci Lett199112916101922971
  • ShaoKHuangRLiJAngiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brainJ Control Release2010147111812620609375
  • SharmaAKZhangLLiSPrevention of MDR development in leukemia cells by micelle-forming polymeric surfactantJ Control Release2008131322022718722489
  • HashemFMAl-SawahliMMNasrMAhmedOAOptimized zein nanospheres for improved oral bioavailability of atorvastatinInt J Nanomedicine2015104059406926150716
  • KimTKKimISHongSHChoiYKKimHYooHHDetermination of dapoxetine in rat plasma by ultra-performance liquid chromatography–tandem mass spectrometryJ Chromatogr B20139264246
  • XuWLingPZhangTPolymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugsJ Drug Deliv2013201334031523936656
  • AdamsMLLavasanifarAKwonGSAmphiphilic block copolymers for drug deliveryJ Pharm Sci20039271343135512820139
  • YooHSParkTGBiodegradable polymeric micelles composed of doxorubicin conjugated PLGA–PEG block copolymerJ Control Release2001701–2637011166408
  • JinCQianNZhaoWImproved therapeutic effect of DOX–PLGA–PEG micelles decorated with bivalent fragment HAb18 F (ab′) 2 for hepatocellular carcinomaBiomacromolecules20101192422243120831277
  • GaucherGSatturwarPJonesMCFurtosALerouxJCPolymeric micelles for oral drug deliveryEur J Pharm Biopharm201076214715820600891
  • SongZFengRSunMCurcumin-loaded PLGA–PEG–PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivoJ Colloid Interface Sci2011354111612321044788
  • WangGWangJJLiFToSSDevelopment and evaluation of a novel drug delivery: pluronics/SDS mixed micelle loaded with myricetin in vitro and in vivoJ Pharm Sci201610541535154326947760
  • XuRZhangYYeXInhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitroFood Chem20131381485323265454
  • MaronpotRRKoyanagiMDavisJSafety assessment and single-dose toxicokinetics of the flavouring agent myricitrin in Sprague–Dawley ratsFood Addit Contam Part A Chem Anal Control Expo Risk Assess201532111799180926365525
  • GhahremankhaniAADorkooshFDinarvandRPLGA–PEG–PLGA tri-block copolymers as an in-situ gel forming system for calcitonin deliveryPolym Bull200759637646
  • WangYWangCGongCPolysorbate 80 coated poly (ɛ-caprolactone)–poly (ethylene glycol)–poly (ɛ-caprolactone) micelles for paclitaxel deliveryInt J Pharm20124341–21822609127
  • KimBSParkSWHammondPTHydrogen-bonding layer-by-layer-assembled biodegradable polymeric micelles as drug delivery vehicles from surfacesACS Nano20082238639219206641
  • JungTKammWBreitenbachAKaiserlingEXiaoJXKisselTBiodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?Eur J Pharm Biopharm200050114716010840198
  • LuoLTamJMaysingerDEisenbergACellular internalization of poly (ethylene oxide)-b-poly (ε-caprolactone) diblock copolymer micellesBioconjug Chem20021361259126512440861
  • NishiyamaNKataokaKCurrent state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene deliveryPharmacol Ther2006112363064816815554
  • BehzadiSSerpooshanVTaoWCellular uptake of nanoparticles: journey inside the cellChem Soc Rev2017464218424428585944
  • IdanIJAbdullahLCMahdiDSObaidMKJamilSNAdsorption of anionic dye using cationic surfactant-modified kenaf core fibersOpen Access Libr J20174118
  • YangQJonesSWParkerCLZamboniWCBearJELaiSKEvading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformationMol Pharm20141141250125824521246
  • DraffehnSEichhorstJWiesnerBKumkeMUInsight into the modification of polymeric micellar and liposomal nanocarriers by fluorescein-labeled lipids and uptake-mediating lipopeptidesLangmuir201632276928693927295095
  • WangJYangGGuoXTangZZhongZZhouSRedox-responsive polyanhydride micelles for cancer therapyBiomaterials20143593080309024388799
  • NanceETimbieKMillerGWNon-invasive delivery of stealth, brain-penetrating nanoparticles across the blood−brain barrier using MRI-guided focused ultrasoundJ Control Release201418912313224979210
  • KulkarniSAFengSSEffects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug deliveryPharm Res201330102512252223314933